AMRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.56%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $52,198,348.02

Amneal Pharmaceuticals Insider Trading History Chart

Amneal Pharmaceuticals Share Price & Price History

^$11.94

▼ -0.24 (-1.97%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Amneal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2025	Ted C. Nark	Director	Sell	50,000	$11.72	$586,000.00	291,029
11/17/2025	Ted C. Nark	Director	Sell	50,000	$11.72	$586,000.00	291,029
11/12/2025	Nikita Shah	EVP	Sell	131,856	$11.92	$1,571,723.52	146,403
8/27/2025	John Kiely	Director	Sell	32,000	$9.23	$295,360.00	225,433
8/25/2025	Nikita Shah	EVP	Sell	6,340	$9.50	$60,230.00	146,403
8/22/2025	Nikita Shah	EVP	Sell	114,492	$9.66	$1,105,992.72	152,743
8/20/2025	Andrew S. Boyer	EVP	Sell	279,244	$9.38	$2,619,308.72	152,426
8/14/2025	Nikita Shah	EVP	Sell	71,694	$9.29	$666,037.26	267,235
8/12/2025	Andrew S. Boyer	EVP	Sell	33,436	$9.05	$302,595.80	256,670
8/12/2025	Jason B Daly	EVP	Sell	22,000	$9.05	$199,100.00	10,606
8/12/2025	Nikita Shah	EVP	Sell	50,000	$9.04	$452,000.00	338,929
3/14/2025	Tushar Bhikhubhai Patel	Major Shareholder	Sell	5,000,000	$8.35	$41,750,000.00	48,578,209
3/3/2025	Gautam Patel	Director	Sell	80,000	$8.90	$712,000.00	1,808,886
2/3/2025	Gautam Patel	Director	Sell	80,000	$8.14	$651,200.00	1,888,886
1/8/2025	Gautam Patel	Director	Sell	62,590	$8.01	$501,345.90	1,968,886
1/2/2025	Gautam Patel	Director	Sell	17,410	$8.01	$139,454.10	2,031,476
11/15/2024	Jason B Daly	SVP	Sell	43,657	$8.61	$375,886.77	13,665
8/11/2023	Andrew S. Boyer	EVP	Sell	29,302	$4.13	$121,017.26	244,739
12/12/2022	Tpg Gp A, Llc	Major Shareholder	Sell	3,884,600	$2.34	$9,089,964.00	12,328,767

SEC Filings (Institutional Ownership Changes) for Amneal Pharmaceuticals (NASDAQ:AMRX)

31.82% of Amneal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Amneal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/21/2025	CIBC Bancorp USA Inc.	16,041	$0.16M	0.0%	N/A	0.005%
11/19/2025	Danske Bank A S	109,121	$1.09M	0.0%	N/A	0.035%
11/18/2025	Advisory Services Network LLC	5,015	$50K	0.0%	N/A	0.002%
11/17/2025	Caxton Associates LLP	134,979	$1.35M	0.0%	N/A	0.043%
11/17/2025	Westshore Wealth LLC	1,381,910	$13.83M	4.7%	N/A	0.440%
11/17/2025	Virtus Advisers LLC	35,921	$0.36M	0.2%	N/A	0.011%
11/17/2025	Voleon Capital Management LP	412,179	$4.13M	0.1%	+564.1%	0.131%
11/17/2025	Verition Fund Management LLC	124,815	$1.25M	0.0%	+252.9%	0.040%
11/17/2025	Qube Research & Technologies Ltd	1,757,653	$17.59M	0.0%	-8.0%	0.559%
11/17/2025	Prelude Capital Management LLC	13,801	$0.14M	0.0%	-63.8%	0.004%
11/17/2025	Nantahala Capital Management LLC	4,224,564	$42.29M	1.5%	-3.3%	1.344%
11/17/2025	Numerai GP LLC	115,906	$1.16M	0.2%	-64.5%	0.037%
11/17/2025	Mariner LLC	395,090	$3.96M	0.0%	-1.1%	0.126%
11/17/2025	Mercer Global Advisors Inc. ADV	10,455	$0.11M	0.0%	N/A	0.003%
11/17/2025	Millennium Management LLC	3,332,751	$33.36M	0.0%	-33.9%	1.060%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	69,553	$0.70M	0.0%	-15.7%	0.022%
11/17/2025	Jain Global LLC	561,661	$5.62M	0.0%	-2.5%	0.179%
11/17/2025	Hamilton Wealth LLC	14,000	$0.14M	0.0%	N/A	0.004%
11/17/2025	Focus Partners Wealth	4,203	$42K	0.0%	N/A	0.001%
11/17/2025	Brevan Howard Capital Management LP	17,079	$0.17M	0.0%	N/A	0.005%
11/17/2025	Capula Management Ltd	145,300	$1.45M	0.0%	N/A	0.046%
11/17/2025	Bank of America Corp DE	662,895	$6.64M	0.0%	+21.7%	0.211%
11/17/2025	Aquatic Capital Management LLC	87,588	$0.88M	0.0%	+84.9%	0.028%
11/17/2025	Algert Global LLC	950,138	$9.51M	0.2%	-8.7%	0.302%
11/17/2025	Alliancebernstein L.P.	312,506	$3.13M	0.0%	+56.1%	0.099%
11/17/2025	Ameriprise Financial Inc.	1,471,636	$14.73M	0.0%	-14.0%	0.468%
11/14/2025	Creative Planning	33,254	$0.33M	0.0%	+39.2%	0.011%
11/14/2025	Lazard Asset Management LLC	54,395	$0.54M	0.0%	-3.6%	0.017%
11/14/2025	Zacks Investment Management	54,551	$0.55M	0.0%	+18.7%	0.017%
11/14/2025	Raymond James Financial Inc.	742,410	$7.43M	0.0%	+3.9%	0.236%
11/14/2025	Bellevue Group AG	7,913	$79K	0.0%	N/A	0.003%
11/14/2025	Rubric Capital Management LP	12,334,941	$123.47M	1.4%	+5.3%	3.927%
11/14/2025	Man Group plc	337,281	$3.38M	0.0%	-6.0%	0.107%
11/14/2025	California State Teachers Retirement System	150,781	$1.51M	0.0%	+16.5%	0.048%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	233,895	$2.34M	0.0%	-50.3%	0.074%
11/14/2025	Two Sigma Investments LP	69,534	$0.70M	0.0%	+291.9%	0.022%
11/14/2025	Squarepoint Ops LLC	540,208	$5.41M	0.0%	-5.6%	0.172%
11/14/2025	Comerica Bank	3,005	$30K	0.0%	+186.7%	0.001%
11/13/2025	Jump Financial LLC	304,597	$3.05M	0.0%	+16.8%	0.097%
11/13/2025	Martingale Asset Management L P	200,203	$2M	0.1%	+29.8%	0.064%
11/13/2025	Arrowstreet Capital Limited Partnership	1,297,762	$12.99M	0.0%	-23.5%	0.413%
11/13/2025	Invesco Ltd.	1,685,386	$16.87M	0.0%	+43.5%	0.537%
11/13/2025	Sei Investments Co.	471,107	$4.72M	0.0%	+3.7%	0.150%
11/13/2025	UBS Group AG	1,445,801	$14.47M	0.0%	-8.7%	0.460%
11/13/2025	BNP Paribas Financial Markets	338,863	$3.39M	0.0%	+65.4%	0.108%
11/13/2025	Kendall Capital Management	25,670	$0.26M	0.1%	+34.4%	0.008%
11/13/2025	Mackenzie Financial Corp	195,804	$1.96M	0.0%	+4.9%	0.062%
11/13/2025	Franklin Resources Inc.	94,012	$0.94M	0.0%	+4.6%	0.030%
11/13/2025	Legal & General Group Plc	164,292	$1.65M	0.0%	+4.2%	0.052%
11/13/2025	Vestcor Inc	23,406	$0.23M	0.0%	+232.4%	0.007%
11/13/2025	Swiss National Bank	303,700	$3.04M	0.0%	+1.4%	0.097%
11/13/2025	WINTON GROUP Ltd	30,415	$0.30M	0.0%	N/A	0.010%
11/13/2025	Russell Investments Group Ltd.	546,030	$5.44M	0.0%	-3.0%	0.174%
11/13/2025	First Trust Advisors LP	619,992	$6.21M	0.0%	-5.0%	0.197%
11/12/2025	Barclays PLC	344,599	$3.45M	0.0%	-16.3%	0.110%
11/12/2025	Dimensional Fund Advisors LP	5,431,134	$54.36M	0.0%	+2.5%	1.729%
11/12/2025	Segall Bryant & Hamill LLC	395,763	$3.96M	0.1%	-5.8%	0.126%
11/12/2025	Rafferty Asset Management LLC	15,443	$0.16M	0.0%	-9.1%	0.005%
11/12/2025	Quantbot Technologies LP	151,520	$1.52M	0.0%	-43.5%	0.048%
11/12/2025	Intech Investment Management LLC	96,414	$0.97M	0.0%	-25.4%	0.031%
11/10/2025	AXQ Capital LP	23,254	$0.23M	0.1%	+40.3%	0.007%
11/10/2025	Ameritas Investment Partners Inc.	12,572	$0.13M	0.0%	-19.4%	0.004%
11/10/2025	Citigroup Inc.	282,862	$2.83M	0.0%	+55.7%	0.090%
11/10/2025	Hillsdale Investment Management Inc.	716,029	$7.17M	0.2%	+89,403.6%	0.228%
11/10/2025	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	44,829	$0.45M	0.0%	-56.7%	0.014%
11/10/2025	China Universal Asset Management Co. Ltd.	55,053	$0.55M	0.0%	-12.5%	0.018%
11/7/2025	GSA Capital Partners LLP	60,550	$0.61M	0.1%	+64.2%	0.019%
11/7/2025	Vanguard Group Inc.	17,954,973	$179.73M	0.0%	+2.3%	5.717%
11/7/2025	JPMorgan Chase & Co.	771,205	$7.72M	0.0%	-42.1%	0.246%
11/7/2025	GF Fund Management CO. LTD.	6,757	$68K	0.0%	-14.8%	0.002%
11/6/2025	LSV Asset Management	197,300	$1.98M	0.0%	+16.1%	0.063%
11/6/2025	Rhumbline Advisers	232,107	$2.32M	0.0%	-2.4%	0.074%
11/6/2025	Versor Investments LP	57,700	$0.58M	0.1%	N/A	0.018%
11/6/2025	Profund Advisors LLC	23,825	$0.24M	0.0%	-16.5%	0.008%
11/6/2025	ProShare Advisors LLC	36,920	$0.37M	0.0%	-13.3%	0.012%
11/5/2025	Savant Capital LLC	10,179	$0.10M	0.0%	-45.2%	0.003%
11/5/2025	Envestnet Asset Management Inc.	160,610	$1.61M	0.0%	N/A	0.051%
11/4/2025	State of Wyoming	56,684	$0.57M	0.1%	+10.2%	0.018%
11/4/2025	Convergence Investment Partners LLC	96,917	$0.97M	0.2%	-39.3%	0.031%
11/4/2025	Thrivent Financial for Lutherans	92,684	$0.93M	0.0%	+60.9%	0.030%
11/3/2025	AlphaQuest LLC	88,561	$0.89M	0.1%	+78.2%	0.028%
11/3/2025	AustralianSuper Pty Ltd	323,443	$3.24M	0.0%	N/A	0.103%
11/3/2025	Truist Financial Corp	13,664	$0.14M	0.0%	N/A	0.004%
10/29/2025	Wealth Enhancement Advisory Services LLC	17,574	$0.18M	0.0%	+31.4%	0.006%
10/28/2025	Ritholtz Wealth Management	103,421	$1.04M	0.0%	-1.3%	0.033%
10/27/2025	Concurrent Investment Advisors LLC	34,705	$0.35M	0.0%	N/A	0.011%
10/24/2025	State of Alaska Department of Revenue	17,070	$0.17M	0.0%	N/A	0.005%
10/23/2025	SG Americas Securities LLC	26,460	$0.27M	0.0%	-73.3%	0.008%
10/20/2025	Allspring Global Investments Holdings LLC	1,135,799	$11.79M	0.0%	+1,440.0%	0.362%
10/15/2025	CWM LLC	29,230	$0.29M	0.0%	+22.0%	0.009%
10/14/2025	Exchange Traded Concepts LLC	3,102	$31K	0.0%	N/A	0.001%
10/9/2025	Voya Investment Management LLC	27,399	$0.27M	0.0%	-37.8%	0.009%
10/7/2025	Assenagon Asset Management S.A.	2,150,041	$21.52M	0.0%	+187.1%	0.685%
8/27/2025	Squarepoint Ops LLC	572,548	$4.63M	0.0%	+276.3%	0.182%
8/19/2025	State of Wyoming	51,459	$0.42M	0.1%	-37.1%	0.016%
8/16/2025	Headlands Technologies LLC	24,692	$0.20M	0.0%	+570.1%	0.008%
8/15/2025	CANADA LIFE ASSURANCE Co	12,604	$0.10M	0.0%	-77.0%	0.004%
8/15/2025	Tower Research Capital LLC TRC	17,768	$0.14M	0.0%	+510.0%	0.006%
8/15/2025	State of Tennessee Department of Treasury	16,397	$0.13M	0.0%	N/A	0.005%
8/15/2025	Voleon Capital Management LP	62,065	$0.50M	0.0%	+33.8%	0.020%

Data available starting January 2016

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Today's Range

Now: $11.94

$11.71

$12.22

50 Day Range

MA: $10.99

$9.72

$12.59

52 Week Range

Now: $11.94

$6.68

$12.68

Volume

2,054,676 shs

Average Volume

1,712,975 shs

Market Capitalization

$3.75 billion

P/E Ratio

597.30

Dividend Yield

N/A

Beta

1.36

Who are the company insiders with the largest holdings of Amneal Pharmaceuticals?: Amneal Pharmaceuticals' top insider shareholders include:
Tushar Bhikhubhai Patel (Major Shareholder)
Gautam Patel (Director)
Nikita Shah (EVP)
Ted C Nark (Director)
Andrew S Boyer (EVP)
John Kiely (Director)
Jason B Daly (SVP)
Jason B Daly (EVP)
Learn More about top insider investors at Amneal Pharmaceuticals.
Who are the major institutional investors of Amneal Pharmaceuticals?: Amneal Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 5.72%
Rubric Capital Management LP — 3.93%
Dimensional Fund Advisors LP — 1.73%
Nantahala Capital Management LLC — 1.34%
Millennium Management LLC — 1.06%
Assenagon Asset Management S.A. — 0.68%
Learn More about top institutional investors of Amneal Pharmaceuticals stock.
Which major investors are selling Amneal Pharmaceuticals stock?: During the previous quarter, AMRX stock was sold by these institutional investors:
Millennium Management LLC
JPMorgan Chase & Co.
Arrowstreet Capital Limited Partnership
Ameriprise Financial Inc.
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
Numerai GP LLC
Qube Research & Technologies Ltd
Nantahala Capital Management LLC
In the previous year, company insiders that have sold Amneal Pharmaceuticals company stock include:
Tushar Bhikhubhai Patel (Major Shareholder)
Gautam Patel (Director)
Nikita Shah (EVP)
Ted C Nark (Director)
Andrew S Boyer (EVP)
John Kiely (Director)
Jason B Daly (SVP)
Learn More investors selling Amneal Pharmaceuticals stock.
Which major investors are buying Amneal Pharmaceuticals stock?: Within the previous quarter, AMRX stock was purchased by institutional investors including:
Assenagon Asset Management S.A.
Westshore Wealth LLC
Allspring Global Investments Holdings LLC
Hillsdale Investment Management Inc.
Rubric Capital Management LP
Invesco Ltd.
Vanguard Group Inc.
Voleon Capital Management LP